Clinical Trial Update: A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A multicenter Phase 4 trial evaluating etanercept and methotrexate for rheumatoid arthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: WITHDRAWN